FDA Investigator

Justin A Boyd

Latest inspection on record: Yongin, South Korea, April 2026 · records back to 2008

Human DrugsFoods & CosmeticsBiologicsAnimal Drugs & FeedsMedical Devices & Rad Health

FDA inspection record · Last updated July 12, 2026

Overview

  • 277 inspections across 238 sites are on record.
  • 1366 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-04-24.

At a glance

Inspections

277

Sites

238

Observations

1,366

Career since

Aug 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Hanlim Pharm Co. Ltd.24 Apr 2026Human DrugsOn file
Rohto-Mentholatum (Vietnam) Co., Ltd.14 Apr 2026Human DrugsOn file
Excel Vision22 Jan 2026Human DrugsView 483 →
Almac Pharma Services Limited28 Nov 2025Human DrugsOn file
Pharmathen International S.A.21 Nov 2025Human DrugsOn file

Sites inspected

Hanlim Pharm Co. Ltd.Yongin, Korea (the Republic of)1 insp.
Rohto-Mentholatum (Vietnam) Co., Ltd.Ho Chi Minh, Vietnam1 insp.
Excel VisionAnnonay, France1 insp.
Almac Pharma Services LimitedCraigavon, United Kingdom1 insp.
Pharmathen International S.A.Rodopi, Greece1 insp.

Co-investigators

Investigators who share inspections with this person.

Charles Cote14 shared
Sandra A Hughes11 shared
Jasjeet K Sekhon9 shared
Jacob W Reynolds5 shared
Ellen C Weisensel5 shared
Justin J Jafferis5 shared
Teresa I Navas4 shared

Full investigator report

Get the verbatim findings behind Justin A Boyd's 1,366 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators